CNS & Neurological Disorders - Drug Targets
Title:Editorial [Hot Topic: COMT as a Drug Target for Nervous System Disorders (Guest Editor: Francesco Papaleo)]
Volume: 11 Issue: 3
Author(s): Francesco Papaleo
Affiliation:
Export Options
About this article
Cite this article as:
Papaleo Francesco, Editorial [Hot Topic: COMT as a Drug Target for Nervous System Disorders (Guest Editor: Francesco Papaleo)], CNS & Neurological Disorders - Drug Targets 2012; 11 (3) . https://dx.doi.org/10.2174/187152712800672508
DOI https://dx.doi.org/10.2174/187152712800672508 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Translocator Protein (18 kDa) in Adult Separation Anxiety and Attachment Style in Patients with Depression
Current Molecular Medicine Why Some Messages Speak Better: Child Immunization in the News and on the Internet
Current Drug Safety The Endocrine Regulation of Stem Cells: Physiological Importance and Pharmacological Potentials for Cell-Based Therapy
Current Stem Cell Research & Therapy Evidence for, and Importance of, cGMP-Independent Mechanisms with NO and NO Donors on Blood Vessels and Platelets
Current Vascular Pharmacology The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in Depression
Current Neuropharmacology Editorial [Hot topic: Parkinsons Disease (Guest Editor: Jurgen Dinges)]
Current Topics in Medicinal Chemistry Pharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults
Current Psychiatry Reviews Hypericin - The Facts About a Controversial Agent
Current Pharmaceutical Design RCAN1 Increases Aβ Generation by Promoting N-glycosylation via Oligosaccharyltransferase
Current Alzheimer Research Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage
Current Neuropharmacology Glutamate-regulated Behavior, Transmitter Release, Gene Expression and Addictive Plasticity in the Striatum: Roles of Metabotropic Glutamate Receptors
Current Neuropharmacology Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Plant Plastid Engineering
Current Genomics Therapeutic Properties of Several Chemical Compounds of <i>Salvia officinalis</i> L. in Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry The Framingham Brain Donation Program: Neuropathology Along the Cognitive Continuum
Current Alzheimer Research Role of Copper in Angiogenesis and Its Medicinal Implications
Current Medicinal Chemistry Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Activators and Inhibitors of the Ion Channel of the NMDA Receptor
Current Drug Targets Intravenous Implanted Neural Stem Cells Migrate to Injury Site, Reduce Infarct Volume, and Improve Behavior after Cerebral Ischemia
Current Neurovascular Research Medicinal Chemistry of A2A Adenosine Receptor Antagonists
Current Topics in Medicinal Chemistry